Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806958 · ClinicalTrials.gov registry record · NA
The PulsePoint Study
A NA study of Cardiovascular Diseases and Heart Diseases, sponsored by Dr. Steven Brooks.
- Recruiting
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 3
- Study locations
NCT04806958: Recruiting NA study of Cardiovascular Diseases and Heart Diseases, sponsored by Dr. Steven Brooks.
NCT04806958 is a NA study of Cardiovascular Diseases and Heart Diseases that is actively recruiting participants, run by Dr. Steven Brooks. The registered enrollment target is 340 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806958, a NA study of Cardiovascular Diseases and Heart Diseases, is actively recruiting participants, sponsored by Dr. Steven Brooks.
- RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized controlled trial will evaluate whether use of the PulsePoint system increases bystander CPR or defibrillator use compared to standard dispatch procedures in patients who suffer non-traumatic, out-of-hospital cardiac arrest in a public location. Half of all suspected cardiac arrest 9-1-1 calls in a public location will receive PulsePoint alerts (treatment arm). The other half of this eligible patient cohort will receive standard dispatch procedures (control arm).
Primary Outcome
Defined as the occurrence of either bystander CPR (chest compressions and or ventilations) or bystander application of a defibrillator prior to the arrival of emergency medical services.
Conditions Studied
Interventions
- OTHER PulsePoint notification
Study Locations (3)
Ohio
- Columbus Division of Fire - Columbus
British Columbia
- British Columbia Emergency Health Services - Vancouver
Manitoba
- Winnipeg Fire Paramedic Service - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2021-06-08 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT04806958 shows while recruiting
NCT04806958 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which PulsePoint notification is the first listed.
NCT04806958 reports a single indexed study location in Ohio, British Columbia, Manitoba.
Frequently Asked Questions
What is clinical trial NCT04806958 about?
NCT04806958 is a clinical study titled "The PulsePoint Study". This randomized controlled trial will evaluate whether use of the PulsePoint system increases bystander CPR or defibrillator use compared to standard dispatch procedures in patients who suffer non-traumatic, out-of-hospital cardiac arrest in a public location. Half of all suspected cardiac arrest 9-...
What is the current status of trial NCT04806958?
This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2021-06-08. Estimated completion is 2026-06-30.
What conditions does trial NCT04806958 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Heart Arrest, Out-Of-Hospital Cardiac Arrest.
What interventions are being tested in trial NCT04806958?
The interventions under investigation include: PulsePoint notification (OTHER).
Who is sponsoring clinical trial NCT04806958?
This trial is sponsored by Dr. Steven Brooks, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04806958 being conducted?
This trial has 3 study locations across Ohio, British Columbia, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04806958's enrollment target sits among peer trials
340 115th of 300 higher than 184 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
- NCT05388864 · 340 participants · NA
Building Resilient Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI